Lamitrode
Payments companies reported to CMS as associated with Lamitrode. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lamitrode, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lamitrode
These are the largest totals companies reported as associated with Lamitrode. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Haley | Pottstown, PA | Physical Medicine & Rehabilitation | $121.03 |
| Chengyuan Wu | Philadelphia, PA | Neurological Surgery | $111.54 |
| Anthony Stefanelli | Philadelphia, PA | Neurological Surgery | $111.53 |
| Carlos Untal | San Luis Obispo, CA | Pain Medicine (Anesthesiology) | $108.01 |
| Richard Rooney | Lompoc, CA | Orthopaedic Surgery of The Spine | $96.58 |
| William Banister | Amarillo, TX | Neurological Surgery | $96.19 |
| James Newton | Columbia, MO | Interventional Pain Medicine | $68.16 |
| Carrie Lucas | Mexico, MO | Nurse Practitioner | $68.15 |
| Thomas Weber | Raleigh, NC | Anesthesiology | $56.35 |
| Michael Yang | Norristown, PA | Sports Medicine (Family Medicine) | $42.38 |
Prescribed Lamitrode?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.